亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北威德利化學科技有限公司  

醫藥原料與醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:魏琦
  • 電話:027-83778875
  • 郵件:15807197853@163.com
  • 傳真:027-83778875
  • QQ:3167471756
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 廠家供應(R)-9-(2-羥基丙基)腺嘌呤
廠家供應(R)-9-(2-羥基丙基)腺嘌呤
單價 260.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后24小時內
庫存 1000KG起訂25KG
品牌 湖北威德利-13971053654
型號 14047-28-0
規格 白色或類白色粉末
過期 長期有效
更新 2016-01-08 10:11
 
詳細信息


(R)-9-(2-羥基丙基)腺嘌呤

生產(R)-9-(2-羥基丙基)腺嘌呤,湖北威德利化學(R)-9-(2-羥基丙基)腺嘌呤 魏琦l3971O53654

中文名 (R)-9-(2-羥基丙基)腺嘌呤,HPA

英文名 R-(+)-9-(2-Hydroxypropyl)adenine

化學名 (R)-(+)-9-(2-羥丙基)腺嘌呤

CAS RN 14047-28-0

分子式 C8H11N5O  分子量 193.2058

性狀 HPA為白色或類白色粉末

純度 HPA>97% 光學純度(ee值)HPA>98%

熔點 192-195℃ 沸點 45.7℃

比旋度 +40°~42°密度 1.57

用途 (R)-9-(2-羥基丙基)腺嘌呤用作富馬酸泰諾福韋的醫藥中間體

包裝 25KG/紙板桶

生產(R)-9-(2-羥基丙基)腺嘌呤,湖北威德利化學(R)-9-(2-羥基丙基)腺嘌呤 魏琦l3971O53654

©2025 湖北威德利化學科技有限公司 版權所有   技術支持:化工網   訪問量:11315  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |